/PRNewswire/ Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced the presentation of.
Shares of Artivion, Inc. (NYSE:AORT – Get Free Report) saw an uptick in trading volume on Monday . 85,488 shares traded hands during mid-day trading, a decline of 55% from the previous session’s volume of 190,634 shares.The stock last traded at $18.57 and had previously closed at $18.24. Analyst Ratings Changes Separately, Needham & Company […]
Artivion, Inc. (NYSE:AORT – Get Free Report) VP John E. Davis sold 13,562 shares of the company’s stock in a transaction on Tuesday, January 2nd. The shares were sold at an average price of $18.00, for a total transaction of $244,116.00. Following the sale, the vice president now owns 128,733 shares of the company’s stock, […]
Needham & Company LLC reiterated their buy rating on shares of Artivion (NYSE:AORT – Free Report) in a research note published on Thursday morning, Benzinga reports. The firm currently has a $22.00 target price on the stock. Artivion Price Performance Shares of NYSE AORT opened at $18.07 on Thursday. The firm has a market cap […]